These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15759034)

  • 41. CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.
    Buhmann R; Kurzeder C; Rehklau J; Westhaus D; Bursch S; Hiddemann W; Haferlach T; Hallek M; Schoch C
    Br J Haematol; 2002 Sep; 118(4):968-75. PubMed ID: 12199774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.
    Shi M; Cipollini MJ; Crowley-Bish PA; Higgins AW; Yu H; Miron PM
    Am J Clin Pathol; 2013 May; 139(5):662-9. PubMed ID: 23596118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
    Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
    Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]   [Full Text] [Related]  

  • 45. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics.
    Amiel A; Arbov L; Manor Y; Fejgin M; Elis A; Gaber E; Lishner M
    Cancer Genet Cytogenet; 1997 Sep; 97(2):97-100. PubMed ID: 9283589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression.
    Dicker F; Schnittger S; Haferlach T; Kern W; Schoch C
    Blood; 2006 Nov; 108(9):3152-60. PubMed ID: 16840733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the East.
    Wu SJ; Lin CT; Huang SY; Lee FY; Liu MC; Hou HA; Chen CY; Ko BS; Chou WC; Yao M; Tang JL; Tsay W; Tien HF
    Ann Hematol; 2013 Jun; 92(6):799-806. PubMed ID: 23417757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL).
    Gozzetti A; Crupi R; Tozzuoli D
    Hematology; 2004 Feb; 9(1):11-5. PubMed ID: 14965864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of CpG ODN on CLL proliferation, apoptosis or phenotype could have an impact on its clinical utility.
    Jahrsdorfer B; Blackwell S; Weiner G
    Leukemia; 2007 Nov; 21(11):2354-5; author reply 2355-6. PubMed ID: 17657215
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetics of lymphocytes influences the emergence of second cancer in chronic lymphocytic leukemia.
    Bernués M; Durán MA; Puget G; Iglesias J; Galán P; Vercher FJ; Besalduch J; Rosell J
    Anticancer Res; 2014 May; 34(5):2311-4. PubMed ID: 24778036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.
    Alhourani E; Aroutiounian R; Harutyunyan T; Glaser A; Schlie C; Pohle B; Liehr T
    J Histochem Cytochem; 2016 Aug; 64(8):495-501. PubMed ID: 27315825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of Gene Abnormalities in 43 Cases of Chronic Lymphocytic Leukemia by Fluorescence in Situ Hybridization].
    Jing Y; Lin S; Wang FT; Yu JW; Jiang F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1038-1043. PubMed ID: 30111404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.
    Wahl U; Nössner E; Kronenberger K; Gangnus R; Pohla H; Staege MS; Kolb HJ; Hallek M; Mocikat R
    Clin Cancer Res; 2003 Sep; 9(11):4240-6. PubMed ID: 14519651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
    Filip AA; Ciseł B; Koczkodaj D; Wąsik-Szczepanek E; Piersiak T; Dmoszyńska A
    Blood Cells Mol Dis; 2013 Apr; 50(4):263-70. PubMed ID: 23313631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expressions of ki-67 and bcl-2 in 29 cases of chronic lymphocytic leukemia and their clinical significance].
    Xu W; Li JY; Wu YJ; Sheng RL; Lu FX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):464-7. PubMed ID: 16800921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia.
    Jamroziak K; Smolewski P; Cebula B; Szmigielska-Kaplon A; Darzynkiewicz Z; Robak T
    Neoplasma; 2004; 51(3):181-7. PubMed ID: 15254670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Holmes PJ; Peiper SC; Uppal GK; Gong JZ; Wang ZX; Bajaj R
    Int J Lab Hematol; 2016 Oct; 38(5):483-9. PubMed ID: 27565124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
    Dubuc AM; Davids MS; Pulluqi M; Pulluqi O; Hoang K; Hernandez-Sánchez JM; Schlich C; Hernández-Rivas JM; Brown JR; Dal Cin P
    Am J Hematol; 2016 Oct; 91(10):978-83. PubMed ID: 27341486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.
    Jak M; Mous R; Remmerswaal EB; Spijker R; Jaspers A; Yagüe A; Eldering E; Van Lier RA; Van Oers MH
    Leuk Lymphoma; 2009 May; 50(5):788-801. PubMed ID: 19452318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization.
    Meyer RG; Van Dyke DL
    Methods Mol Biol; 2019; 1881():35-49. PubMed ID: 30350196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.